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Introduction
Dying is often accompanied by pain which is severe enough to make
living unbearable. An interdisciplinary approach to the palliation of
pain can, in most instances, bring sufficient relief and assure comfort
and dignity during one’s final days. This degree of pain relief should
be available to all. To assure that it is, the following recommenda
tions are made:
• That the Agency for Healthcare Policy and Research and American
Pain Society guidelines for the treatment of pain be accepted as the
standard of care for all healthcare providers.1’2
• That the right to skilled pain management in the dying patient be
included in the “Patient’s Bill of Rights” at all DOH certified and!
or licensed facilities.
• That the Department of Health be empowered and directed by
legislation or executive action to use these standards in developing
measurable, enforceable objectives by which the adequacy of pain
management in those institutions and by those providers can be
measured.
• That these measurements be carried out routinely as part of the
DOH periodic reviews and that citations be issued to those failing to
comply.
• It is the intention of the committee that the term “Cancer Pain” be
broadened to include all patients dying with pain.
Minimum Standards
1. Evidence that specially designated caregivers are available to
dying patients with pain who have been trained in pain control and
who have the authority to administer this care.
2. That an assessment of pain be made part of the initial assessment
of all patients dying with pain.
*3 To assure optimal pain management, formal means should be
developed and used within each institution for evaluating pain
management practices and for obtaining patient feedback to gauge
the adequacy of its control. The quality of pain management should
be evaluated in all settings where patients (with cancer) receive care.
*4 The quality of (cancer) pain management should be evaluated at
the points of transition on the provision of services (e.g., from the
hospital to the home) to determine that optimal pain management is
achieved and maintained.
*5 For pain management to be effective, each practice setting
should designate who will be responsible for pain management.
*6. Policy and standard procedures, which define the acceptable
level of patient monitoring and appropriate roles and limits of
practice for health care providers, should govern the use of special
ized analgesic technologies.
*7 To ensure optimal pain management, formal means should be
developed and used within each institution for evaluating (cancer)
pain management practices and should include feedback regarding
the adequacy of pain relief. Optimal pain management requires the
interaction of all members of the health care team, including the
patient. A formal process should be developed to evaluate the
quality of management across all stages of the disease and across all
practice settings.
(*Standards No.3 through No.7 are verbatim from the “Manage
ment of Cancer Pain”1 page 143).
Institutions to be Monitored
1. Acute care hospitals
2. Skilled nursing/intermediate care facilities
3. Community based settings (eg. Residential care homes)
4. Hospice programs
5. Home health!home-care agencies
Other Recommendations
I. Problems exist in the referral practices Hospice Care and must be
addressed. This includes the restrictive prognostication guidelines
of “Six months of life or less” and therefore we recommend that
the State of Hawaii mandate benefits for Hospice Care with a one
year or less life expectancy. Continued on p.93
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rounded by love. With the support of a hospice team, patients can die
the same way. If the sages are to be believed, love is the only thing
that goes with us into death.
Hospice care is generally delivered in the patient’s own home.
Many families worry that patients must be in the hospital for pain
management to be effective. Although pain management is quite
effective in the home setting, the less “technical” methods of
administration of pain medication tend to work better in the home
with family members as caregivers. A restriction hospices have been
facing since the inception of the Hospice Medicare Benefit is cost
containment. This restriction is also rapidly coming to the forefront
in the hospital setting. In hospice, the pain must be effectively
managed at the lowest possible cost, since reimbursement to hos
pices is given on a per-diem basis, with no consideration given to the
particular treatments offered. In the home setting, the challenge is to
keep the interventions “human scale.” That means that in general
highly technological interventions create much anxiety among lay
caregivers. This concept is supported by the World Health Organi
zation and the U.S. Public health Service.5By keeping the methods
of medication administration away from the highly technical in the
hospice setting, both the goals of reducing family anxiety and cost
containment are met.
Transdermal fentanyl is an efficacious medication in the terminal
setting. Its advantages include infrequent dosing, fewer side effects
compared to P0 opiates, ability to continue dosing when the oral
route is not available (such as when death is imminent) and good
control of pain. Hospices consider the relative high cost of this
medication to be outweighed by its advantages. On the other hand,
PCA pumps or other parenteral modalities can be intimidating to
families in the home setting and are even more costly. On occasion
PCA pumps are necessary, but use on a large scale would make it
impossible for most hospices to operate within the financial con
straints with which they must function.6The proper use of adjuvant
medications such as NSAIDS andJor steroids for bone cancer pain,
and anticonvulsants or antidepressants for neuropathic pain along
with the opiates can also be critical factors in the comfort and
therefore quality of life during the endstage.
An often overlooked route of administration not only for opiates
but other medications is the rectal route. Though P0 administration
remains the preferred route, the rectal route is a simple technique of
administration with a comparable reliability of absorption and low
cost as the oral route.7 The rectal route is also available when the
patient can no longer swallow as death approaches. Most family
members can be easily taught rectal administration.
Respiratory problems frequently require palliation in the hospice
setting. Lung cancer is the most common terminal cancer diagnosis.
Many lethal cancers tend to metastasize to the lungs. Radiation or
chemotherapy may result in compromised pulmonary function.
Ascites from abdominal cancers may contribute to dyspnea. Com
fort is often restored with low dose morphine, anxiolytics, oxygen
administration, steroids, possibly P0 antibiotics in the case of
pneumonia, and/or paracentesis for ascites.8
Other uncomfortable symptoms often addressed in the hospice
setting include nausea and constipation. Fortunately medical man
agement of nausea is a realistic goal today with the variety of
effective medications available. Even difficult to control nausea
often responds to “BDR” suppositories, consisting of Benadryl
25mg, Decadron 4mg, and Reglan 20mg.
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2. Benefits for Medicare and Medicaid accepted pain management
services (including but not limited to, surgical and/or radiation
intervention) needs to be provided independently from the daily
hospice coverage allowance.
3. Educational coursework in pain management should be encour
aged and supported in the Continuing Education curricula at all
DOH reviewed facilities for all licensed healthcare personnel.
4. Although it is recommended that pain management services be
readily available and easily accessed, it is not the intent of this panel
to legislate mandatory referral of patients to a “Pain Specialist.”
Through appropriate education and awareness of services already
available, the patient’s primary physician should be able to treat pain
adequately. If the primary physician is unable to control the patient’s
symptoms, referral to the appropriate services (eg. pain manage
ment specialist, hospice, pain team, etc.) should be made.
5. We recommend that existing professional organizations be di
rected to develop standards for pain management and that they
incorporate methods to assure quality in this area (eg. Peer review.
Continuous Quality Improvement. Quality Assurance, etc.)
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